drugset / Trial / NCT00371098
Influenza Vaccination in Prevention From Acute Coronary Events in Coronary Artery Disease - FLUCAD Study
Phase 2/3
Completed
658 enrolled
National Institute of Cardiology, Warsaw, Poland
Solvay Pharmaceuticals · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Background: Influenza vaccination is recommended in patients (pts) with cardiovascular disease, however there is a shortage of clinical studies proving its protective effect on clinical course of coronary artery disease (CAD). The aim of the study was to evaluate the effect of influenza vaccination on the incidence of coronary events in pts with CAD confirmed by coronary angiography.
Timeline
- Start
- 2004-10
- Primary completion
- —
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Influenza Virus Vaccine | Vaccine | — | — |